2320-6691 2015; 3(3B):1132-1136 ISSN 2347-954X



Similar documents
Introduction to Electrophysiology. Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center

Assessment, diagnosis and specialist referral of adults (>16 years) with an episode of transient loss of consciousness (TLoC) or a blackout.

Tachyarrhythmias (fast heart rhythms)

Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses

Basics of Pacing. Ruth Hickling, RN-BSN Tasha Conley, RN-BSN

Recurrent AF: Choosing the Right Medication.

Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI)

COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION

Autonomic Stress Test

HTEC 91. Topic for Today: Atrial Rhythms. NSR with PAC. Nonconducted PAC. Nonconducted PAC. Premature Atrial Contractions (PACs)

5/1/2015. When should I worry? Presyncope is the feeling that one is about to pass out but remains conscious with a transient loss of postural tone.

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

Potential Causes of Sudden Cardiac Arrest in Children

8 Peri-arrest arrhythmias

Clinical Glidepath TM Tools Syncope Frail Life expectancy less than five years or significant functional impairment

Ngaire has Palpitations

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

Equine Cardiovascular Disease

Cardiac Syncope. spot it, stop it! Syncope is Tranient Loss of Consciousness (T- LOC) due to: transient global cerebral hypoperfusion

Catheter Ablation. A Guided Approach for Treating Atrial Arrhythmias

Professor Rose Anne Kenny, St James Hospital &Trinity College, Dublin

The P Wave: Indicator of Atrial Enlargement

Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose

GUIDELINE 11.9 MANAGING ACUTE DYSRHYTHMIAS. (To be read in conjunction with Guideline 11.7 Post-Resuscitation Therapy in Adult Advanced Life Support)

Syncope 2015: Evaluation and Treatment. Steve Greer, MD FHRS BHHI Primary Care Symposium February 27, 2015

Approach to the Patient with Syncope

510(k) Summary May 7, 2012

ACLS PHARMACOLOGY 2011 Guidelines

NEONATAL & PEDIATRIC ECG BASICS RHYTHM INTERPRETATION

22 Arrhythmias. C. Scharf and F. Duru. Siegenthaler, Differential Diagnosis in Internal Medicine (ISBN ), 2007 Georg Thieme Verlag

Introduction. What is syncope?

Il loop recorder esterno. Roberto Maggi

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Diana Heiman, MD Associate Professor, Family Medicine Residency Director East Tennessee State University

Neurocardiogenic Syncope

Conflicts of interest: None

By the end of this continuing education module the clinician will be able to:

An Introduction to Tachyarrhythmias R. A. Seyon MN, NP, CCN(C) & Dr. R. G. Williams

Atrial & Junctional Dysrhythmias

Interpreting AV (Heart) Blocks: Breaking Down the Mystery

Guidelines on management (diagnosis and treatment) of syncope*

Signal-averaged electrocardiography late potentials

Electrophysiology Heart Study - EPS -

Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI

ACLS Cardiac Arrest Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767

Atrial Fibrillation An update on diagnosis and management

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center

ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol

Normal Sinus Rhythm. Sinus Bradycardia. Sinus Tachycardia. Rhythm ECG Characteristics Example (NSR) & consistent. & consistent.

INTRODUCTORY GUIDE TO IDENTIFYING ECG IRREGULARITIES

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Medtronic Cardiac Rhythm and Heart Failure ICD-10 Coding for Physicians

Presenter Disclosure Information

VCA Veterinary Specialty Center of Seattle

Bradycardia CHAPTER 12 CODE SCENARIO

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services

«Δυσλειτουργία βηματοδότη. Πως μπορούμε να την εκτιμήσουμε στο ιατρείο.» Koσσυβάκης Χάρης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ

School of Health Sciences

Atrial fibrillation. Quick reference guide. Issue date: June The management of atrial fibrillation

Patient Information Sheet Electrophysiological study

Crash Cart Drugs Drugs used in CPR. Dr. Layla Borham Professor of Clinical Pharmacology Umm Al Qura University

Atrial Fibrillation Management Across the Spectrum of Illness

Episode 20 Atrial fibrillation Prepared by Dr. Lucas Chartier

Electrocardiographic Issues in Williams Syndrome

CARDIAC ELECTROPHYSIOLOGY, ARRHYTHMIAS AND PACING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational

Electrocardiography I Laboratory

Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015

SYNCOPE a symptom, not a diagnosis

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?

How To Understand What You Know

About the British Heart Foundation

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust

Consensus statement for the diagnosis and management of syncope. Argentine Society of Cardiology

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

Present : PGY 王 淳 峻 Supervisor: F1 王 德 皓

ACLS PRE-TEST ANNOTATED ANSWER KEY

TOP 5. The term cardiac arrhythmia encompasses all cardiac. Arrhythmias in Dogs & Cats. Sinus Arrhythmia. TOP 5 Arrhythmias Seen in Dogs & Cats

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39

HEART HEALTH WEEK 3 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease HEART FAILURE. Relatively mild, symptoms with intense exercise

Atrial fibrillation (AF) care pathways. for the primary care physicians

Perioperative Cardiac Evaluation

Atrial Fibrillation The Basics

Tilt Table Testing for Assessing Syncope

Atrial Fibrillation Cardiac rate control or rhythm control could be the key to AF therapy

TABLE 1 Clinical Classification of AF. New onset AF (first detected) Paroxysmal (<7 days, mostly < 24 hours)

Atrial Fibrillation Peter Santucci, MD Revised May, 2008

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

Quiz 4 Arrhythmias summary statistics and question answers

Michael Hartman, CRNA, DNP, MSN, BSN, BA

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements

Electrocardiography Review and the Normal EKG Response to Exercise

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

Transcription:

Scholars Journal of Applied Medical Sciences (SJAMS) Sch. J. App. Med. Sci., 2015; 3(3B):1132-1136 Scholars Academic and Scientific Publisher (An International Publisher for Academic and Scientific Resources) www.saspublisher.com ISSN 2320-6691 (Online) ISSN 2347-954X (Print) Review Article Diagnostic Evaluation of Syncope Narayan Chandra Sarkar 1*, Siddhant Jain 2, Piyabi Sarkar 3 1,2 Associate Professor, Department of Cardiology, Sri Aurobindo Medical College and Post Graduate Institute, Indore, India 3 PG Resident, Institute of Post Graduate Medical Education and Research and SSKM Hospital, Kolkata, India *Corresponding author Dr. Narayan Chandra Sarkar Abstract: Syncope is a complex clinical problem frequently confronts by primary care physician. At the age of 60-70 years, 5-20% adult may experience one or more syncopal episodes. 6% of hospital admission and 3% of emergency visit are due to syncopal accounts. Careful history taking and clinical examination may evaluate the cause of syncope in about 50% of cases. The evidence base methodical approach decreases hospital admission and unnecessary costly diagnostic and therapeutic procedures. Keywords: Syncope, ECG, Holter monitoring, SA ECG, Loop recorder SNRT, SACT, E P Study. INTRODUCTION Syncope is defined as sudden, transient loss of consciousness which resolves spontaneously without any intervention. It is a complex clinical problem frequently confronted by primary care physician. Patients with syncope not diagnosed by initial clinical evaluation and ECG are usually referred for 24 hours ambulatory Holter monitoring. At the age of 60-70 yrs. 5% to 20% adult may experience one or more syncopal episodes. 6% of hospital admission and 3% of emergency visit are due to syncopal account [1, 2]. CAUSES OF SYNCOPE They include cardiac and non-cardiac causes. Cardiac causes: Arrhythmic and Non-Arrhythmic. Arrhythmic causes of syncope SA node disease: Sinus bradycardia, Sinus pause, Sinus arrest, Sinus exit block, Sick sinus syndrome (SSS), Chronotropic incompetence. AV node disease: Complete AV block, Bifascicular block, Mobiz II type 2 nd degree AV block, Sick sinus syndrome, Ventricular tachycardia/ Ventricular fibrillation /SVT with Low BP. Non-arrhythmic cardiac cause of syncope: Aortic Stenosis, Acute myocardial infarction, Pulmonary embolism, Pulmonary hypertension, Aortic dissection, Carotid sinus hypersensitivity, Left atrial myxoma. Non-cardiac cause of syncope Transient Ischemic attack, Neutrally mediated syncope, Vasovagal syncope, Subclavian steal, Seizure disorder, Situation syncope (cough, micturation & defecation) nad drug induced. Drug causing syncope Nitrate Anti hypertensive agents: Beta blocker, Calcium channel blockers, ACE inhibitors /ARBs Anti arrhythmic & hypoglycemic agents Psycotherapeutic drugs. PATHOPHYSIOLOGY OF CARDIAC SYNCOPE There are four pathophysiological mechanisms: Transient reduction of cerebral blood flow due to CHB, LVOT and/or pulmonary embolism. Cardiac arrhythmia may reduce cardiac output and leads to syncope. Vasomotor instability may transiently decrease systemic vascular resistance and /or venous return may leads to hypotension & syncope. Drugs: Variety of drugs may cause orthostatic hypotension and /or arrhythmia reduces cerebral blood flow and may cause syncope. DIAGNOSTICS TEST IN EVALUATION OF SYNCOPE History and physical examination. Non- invasive: ECG, Echocadigraphy, Holter monitoring, Signal average ECG (SAECG); 1132

Loop recorder/ event recorder, Autonomic function test (Carotid sinus massage, Pharmacological test, Upright -tilt table test). Invasive test: SNRT (Sinus node reactivation time), SACT (Sinoatrial conducted time), EP study (Electrophysiological study). HISTORY AND PHYSICAL EXAMINATION Careful history taking and physical examination may determine the cause of syncope in about 50% of the cases[3,9] orthostatic hypertension, cardioinhibitory reaction and situational syncope are diagnosed only by history taking and /or by physical examination[3,9,10]. Dizziness should not be considered as syncope. Eyewitness is helpful for evaluation for pre-syncopal, syncopal and post syncopal episodes[8,9]. Physical examination is important when the patient is not able to describe the event or no eyewitness is available. Following physical note should be taken. Carotid burit. Neurological deficits. Cardiac murmurs. Extra heart sound as tumor plop. Peripheral pluses for evidence of peripheral vascular disease. Dermatological examination for collagen vascular diseases or vasculitis. BP shout be checked in both arms and also in standing position for orthostatic hypotension. Funduscopic examination of eye for an embolic source. ECG Sinus bradycardia with rate of < 40 BPM in the awaken state. Inappropriate bradycardia- heart rate does not increase with exercise. Sinoatrial exit block : SA node depolarize but fail to exit. Pause is multiple of sinus PP interval. Sinus pause or sinus arrest : Fail to depolarize SA node in time. >3 second pause is significant. Pause is not multiple of sinus PP interval. 1 st degree SA block: Progressive prolongation of SA node conduction and intermittent failure of impulse formation not apparent on the ECG. 2 nd SA block: Intermittent absence of P wave resulting irregularly irregular atrial rhythm. 3 rd degree SA block: No P wave in the ECG. A-Vdissociation (3 rd degree A-V block), 2:1 block, second-degree A-V block(mobiz type-ii) Bifascicular /trifascicular block, prolong QT interval > 400msec. WPW syndrome. In asymptomatic patient level of A-V block evaluation: Block in A-V node: Carotid sinus massage and vagal stimulation slow heart rate. Exercise, Atropine and isoproterenol increase heart rate. Infranodal block: Carotid sinus massage Vagal stimulation exercise and atropine have less effect on heart rate. Congenital heart block: Narrow QRS complex and increase heart rate with exercise. Acquired heart block: Wide QRS complex and heart rate does not increase with exercise. ECHOCARDIOGRAPHY It may exclude organic heart disease especially aortic stenosis or hypertrophic Cardiomyopathy. HOLTER MONITORING Holter monitoring is one of the most commonly used test of evaluation of syncope: It may reveal significant sinus pause>3 sec., 2:1 AV block/intermittent complete AV block/arrhythmia such as AF/non sustained VT etc. for cause of syncope. EVALUATION OF AUTOMATIC DYSFUNCTION Carotid sinus massage: unilateral massage of carotid sinus for 5 second may lead to sinus pause /sinus arrest for > 3 second and/or fall of BP > 50 mmhg in autonomic dysfunction. Tilt-table test: This is a provocation test to evaluate vasovagal syndrome. The patient is maintained in upright position on a tilt- table for defined periods to induce vasovagal episodes. West minister till-table protocol: Test is perform in morning in the fasted state. Vasoactive drugs to be stopped for 2 days before test. Patient is kept in supine state for 30 minutes. BP and heart rate are recorded. Table is tilted to 60 0 upright angle for upto 20 to 45 minutes and patient is asked to report any symptoms. Test is terminated if bradycardia and /or hypotension occur in association with symptoms. Three types of response may be noted. a) Vasopressor response : Fall of BP due to vasodilatation b) Cardio inhibitory: Bradycardia may be followed by hypotension. c) Mixed response: Bradycardia and hypotension. Pharmacological Testing It will differentiate between sinus node dysfunction and autonomic dysfunction. Total autonomic blockade: Injection Atropine 0.04 mg/kg and Propranolol 0.2 mg/kg, I.V to be given. This will blocked autonomic influence on S A node resulting intrinsic heart rate intact.intrinsic heart rate= 117.2-(0.53 x age).intrinsic heart rate lower than predicted heart rate infers sinus node 1133

dysfunction.if close to normal then autonomic dysfunction. SIGNAL-AVERAGE ECG A device which records 100-300 single QRS complexes which are amplified and filtered for noise and averaged to determine the presence of late potentials which are low amplitude, high frequency signal in the terminal segment of the amplified QRS. It predicts life threatening VT in future. LOOP RECORDER Loop recorders effectively couple arrhythmia and syncope. They are used in patients with recurrent frequent syncope and can monitor for weeks to months. External loop recorder The recorder can capture previous arrhythmia for 4 to 5 minutes of rhythm data during syncopal episodes if the patient activates it after regaining consciousness. Implantable loop recorder This is a implantable device similar to pacemaker. It continuously records a single lead ECG and has the capacity to store for 15 minutes segment of cardiac rhythm when activated during or after syncopal episode. The physician can later retrieve this information. It is almost 3 times as likely to provide a diagnosis by prolonged monitoring in the patients with unexplained syncope of arrhythmic origin as other standard testing such as tilt-table test, EP study and external loop recorder. INVASIVE TESTS SNRT (Sinus node recovery time): Right atrium paced faster than sinus for 30 second- all pacing complex-abruptly stopped pacing- spontaneous sinus beat recorded. If recovery time is > 15,000 msc is abnormal. Corrected sinus node recovery time = recovery time sinus cycle length > 550 msc. Suggestive of sinus node dysfunction. SACT (Sinoatrial node conduction time) Atrial rate is determined (A1-A1 interval i e time between P wave). Right atrium is paced and PAC is produced and marked as A2 (without p-wave)- pacing is stopped and spontaneous atrial response noted A3. SACT =A2-A3 interval-(a1-a1 interval) Or SACT= Spontaneous cycle length return cycle length 2 Normal range 50-125msc. Prolonged SACT indicates susceptibility to exit block. If SACT = A1-A1 interval then automaticity is normal. EP Study (Electrophysiological Study): An invasive study. Fowling are the indications of EP study Evaluation of bradycardia: Sinus node dysfunction: Symptomatic patients with suspected sinus node. Disease, where the link between arrhythmia and symptoms is not established noninvasively. It can detect sinus node recovery time (SNRT) and sinoatrial conduction time (SACT). Known sinus node dysfunction to evaluate A-V node function during permanent Pacemaker implantation. SITE OF BLOCK To evaluate site of A-V block: A-H interval 60-125 msc (normal),h-v interval 35-55 msc (normal). In the A-V node: Normal QRS complex and A-H interval >125 msc. Infranodal block (His Purkinje): Wider QRS complex and H-V interval > 55 msc. Both side block: ECG bundle branch block and both A-H and H-V interval are prolonged. Evaluation of Tachyarrhythmias It is useful in evaluation of reentrant tachyarrhythmia. It detects anatomic or physiologic substrate responsible for arrhythmia and defines electrical mechanism, Hemodynamic response and guides therapy. TACHYCARDIA WITH NARROW QRS COMPLEX Frequent symptoms, where EP characterization will determine the treatment and where drugs are ineffective /poorly tolerated/ not wanted. TACHYCARDIA WITH BROAD QRS COMPLEX Where diagnosis of tachycardia are not determined by surface ECG, where will determine by line of treatment as well as diagnosis. WOLFF-PARKINSON-WHITE SYNDROME (WPW SYNDROME) Evaluation for RF ablation. Patients with unexplained syncope or resuscitated Cardiac arrest Patients in whom knowledge of accessory Pathway properties may determine requirement for treatment (e.g high risk occupation). EVALUATION OF UNEXPLAINED SYNCOPE Suspected or know structural heart disease in which non invasive testing fails to establish diagnosis especially elderly patients with symptomatic bradycardia. Recurrent unexplained syncope after negative tilttable testing EVALUATION OF CARDIAC ARREST SURVIVORS Cardiac arrest in absence of myocardial infarction. 1134

Cardiac arrest > 48 hours after acute MI, in absence of recurrent myocardial ischemia. Cardiac arrest causes by bradycardia. EVALUATION OF PALPITATIONS Palpitation preceding syncopal episode Documented inappropriately rapid pulse rate in absence of adequate ECG in documentation of arrhythmia EP GUIDELINE OF DRUG THERAPY In VT /VF cardiac arrest, sustained VT Guiding drug therapy in narrow QRS complex tachycardia (rarely used) as RF ablation is the treatment of choice. Fig. 1: Algorithm for evaluation of syncope CONCLUSION Syncope is a common but complex clinical symptom. Its etiology is not always easily identified. Careful history taking and meticulously related clinical examination is very important and may pick up the cause of syncope in about 50% of cases. Stepwise following of the Algorithm is important in order to identify the cause of syncope without unnecessary costly investigations. 1135

REFERENCES 1. Day SC, Cook EF, Funkenstein H, Goldman L; Evaluation and outcome of emergency room patients with transient loss of consciousness. The American journal of medicine, 1982;73(1):15-23. 2. Silverstein MD, Singer DE, Mulley AG, Thibault GE, Barnett GO; Patients with syncope admitted to medical intensive care units. Jama, 1982;248(10): 1185-1189. 3. Kapoor WN, Karpf M, Levey GS; Issues in evaluating patients with syncope Ann Intern Med, 1984;100:755-757. 4. Gibson TC, Heitzman MR; Diagnostic efficacy of 24-hour electrocardiographic monitoring for syncope. The American journal of cardiology, 1984; 53(8):1013-1017. 5. Kapoor WN, Karpf M, Wieand S, Peterson JR, Levey GS; A prospective evaluation and follow-up of patients with syncope. New England Journal of Medicine, 1983;309(4):197-204. 6. Lipsitz LA, Wei JY, Rowe JW; Syncope in an elderly, institutionalised population: prevalence, incidence, and associated risk. QJM, 1985; 55(1): 45-54. 7. Martin GJ, Adams SL, Martin HG, Mathews J, Zull D, Scanlon PJ; Prospective evaluation of syncope. Annals of emergency medicine, 1984; 13(7):499-504. 8. Stults BM, Gandolfi RJ; Diagnostic evaluation of syncope. Western Journal of Medicine, 1986; 144(2): 234. 9. Calkins H, Shyr Y, Frumin H, Schork A, Morady F; The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope. The American journal of medicine, 1995; 98(4): 365-373. 10. Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, Levy D; Incidence and prognosis of syncope. New England Journal of Medicine, 2002; 347(12): 878-885. 1136